Viewing data from:

METHOCARBAMOL

ANDA

METHOCARBAMOL | A090200 | HETERO LABS LTD UNIT III

2 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 8 NDCs

Highest NADAC/Unit

$0.0429

per ea

Lowest NADAC/Unit

$0.0390

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
31722053401METHOCARBAMOL 750 MG TABLET	$0.0429	EA	Generic	—	2026-06-17
60687056801METHOCARBAMOL 750 MG TABLET	$0.0429	EA	Generic	—	2026-06-17
31722053405METHOCARBAMOL 750 MG TABLET	$0.0429	EA	Generic	—	2026-06-17
50268052115METHOCARBAMOL 750 MG TABLET	$0.0429	EA	Generic	—	2026-06-17
60687055901METHOCARBAMOL 500 MG TABLET	$0.0390	EA	Generic	—	2026-06-17
31722053305METHOCARBAMOL 500 MG TABLET	$0.0390	EA	Generic	—	2026-06-17
31722053301METHOCARBAMOL 500 MG TABLET	$0.0390	EA	Generic	—	2026-06-17
50268052015METHOCARBAMOL 500 MG TABLET	$0.0390	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 4 NDCs, 4 NC)

Lowest Price

$2.95

Highest Price

$16.07

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
72865-0233-01METHOCARBAMOL 500MG TAB	$2.95	NC	XLCare Pharmaceuticals, Inc.	03/22/2027
72865-0233-05METHOCARBAMOL 500MG TAB	$12.97	NC	XLCare Pharmaceuticals, Inc.	03/22/2027
72865-0234-01METHOCARBAMOL 750MG TAB	$3.63	NC	XLCare Pharmaceuticals, Inc.	03/22/2027
72865-0234-05METHOCARBAMOL 750MG TAB	$16.07	NC	XLCare Pharmaceuticals, Inc.	03/22/2027

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain10 active DMFs21 inactive

8 active API suppliers hold Drug Master Files for this ingredient.

BOEHRINGER INGELHEIM CHEMICALS INCMETHOCARBAMOL

DMF 59541985

SYNTHOKEM LABS PRIVATE LTDMETHOCARBAMOL USP

DMF 104101993

SEVEN STAR PHARMACEUTICAL CO LTDMETHOCARBAMOL

DMF 155962001

GRANULES INDIA LTDMETHOCARBAMOL USP

DMF 178722004

ZHEJIANG APELOA JIAYUAN PHARMACEUTICAL CO LTDMETHOCARBAMOL API

DMF 196572006

ZHEJIANG HAIZHOU PHARMACEUTICAL CO LTDMETHOCARBAMOL USP

DMF 311122016

ZHEJIANG HAIZHOU PHARMACEUTICAL CO LTDMETHOCARBAMOL

DMF 336592019

ZHEJIANG HAIZHOU PHARMACEUTICAL CO LTDMETHOCARBAMOL (PROCESS ISOPROPANOL)

DMF 374362023

DELTA SYNTHETIC CO LTDMETHOCARBAMOL

DMF 386312023

APITORIA PHARMA PRIVATE LTDMETHOCARBAMOL USP

DMF 426542025

PENCO OF LYNDHURST INCInactiveMETHOCARBAMOL

DMF 2321956

CHRISTIAN BRUNNENGRABER AND COInactiveMETHOCARBAMOL

DMF 8661964

ORION CORP FERMIONInactiveMETHOCARBAMOL NF XV

DMF 40361980

TIANJIN MEDICINES & HEALTH PRODUCTS IMPORT AND EXPORT COInactiveMETHOCARBAMOL

DMF 41101981

ORGAMOL SAInactiveMETHOCARBAMOL

DMF 48281983

EASTMAN CHEMICAL COInactiveMETHOCARBAMOL USP

DMF 49801983

SYNTHAInactiveMETHOCARBAMOL

DMF 51361983

ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIVInactiveMETHOCARBAMOL

DMF 53741984

OMNICHEM NVInactiveMETHOCARBAMOL USP

DMF 56671985

ORION CORP LTDInactiveMETHOCARBAMOL

DMF 63891985

HEXAGON LABORATORIES INCInactiveMETHOCARBAMOL

DMF 64681986

LASA LABORATORIOS SAInactiveMETHOCARBAMOL

DMF 66421986

CIPLA LTDInactiveMETHOCARBAMOL

DMF 67051986

PENCO OF LYNDHURST INCInactiveMETHOCARBAMOL

DMF 67731987

SIANG TA PHARMACEUTICAL CO LTDInactiveMETHOCARBAMOL

DMF 108331994

CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTDInactiveMETHOCARBAMOL USP

DMF 130801998

LABORATORIES ARGENOI SLInactiveMETHOCARBAMOL, MAUFACTURED IN ZARAGOZA, SPAIN

DMF 140121999

BIDACHEM SPAInactiveMETHOCARBAMOL

DMF 149062000

BENTLEY API SLInactiveMETHOCARBAMOL

DMF 158752002

SEVEN STAR PHARMACEUTICAL CO LTDInactiveMETHOCARBAMOL DC 90%

DMF 202752007

ZHEJIANG JIANFENG HAIZHOU PHARMACEUTICAL CO LTDInactiveMETHOCARBAMOL

DMF 267682012

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 500MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Nov 6, 2009

No patent or exclusivity listings for this strength.

#002 — 750MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Nov 6, 2009